BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28749713)

  • 1. Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.
    Koren G
    Expert Opin Drug Saf; 2017 Nov; 16(11):1227-1234. PubMed ID: 28749713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.
    O'Donnell A; McParlin C; Robson SC; Beyer F; Moloney E; Bryant A; Bradley J; Muirhead C; Nelson-Piercy C; Newbury-Birch D; Norman J; Simpson E; Swallow B; Yates L; Vale L
    Health Technol Assess; 2016 Oct; 20(74):1-268. PubMed ID: 27731292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2015 Mar; 15():59. PubMed ID: 25884778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.
    Mazzotta P; Magee LA
    Drugs; 2000 Apr; 59(4):781-800. PubMed ID: 10804035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum.
    Koren G; Maltepe C
    J Obstet Gynaecol; 2004 Aug; 24(5):530-3. PubMed ID: 15369934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review.
    McParlin C; O'Donnell A; Robson SC; Beyer F; Moloney E; Bryant A; Bradley J; Muirhead CR; Nelson-Piercy C; Newbury-Birch D; Norman J; Shaw C; Simpson E; Swallow B; Yates L; Vale L
    JAMA; 2016 Oct; 316(13):1392-1401. PubMed ID: 27701665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy.
    Ashkenazi-Hoffnung L; Merlob P; Stahl B; Klinger G
    Isr Med Assoc J; 2013 Jan; 15(1):23-6. PubMed ID: 23484234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacologic management of nausea and vomiting of pregnancy.
    Niebyl JR; Briggs GG
    J Fam Pract; 2014 Feb; 63(2 Suppl):S31-7. PubMed ID: 24527483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary approaches to hyperemesis during pregnancy.
    Tan PC; Omar SZ
    Curr Opin Obstet Gynecol; 2011 Apr; 23(2):87-93. PubMed ID: 21297474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nausea and vomiting of pregnancy and hyperemesis gravidarum.
    Fejzo MS; Trovik J; Grooten IJ; Sridharan K; Roseboom TJ; Vikanes Å; Painter RC; Mullin PM
    Nat Rev Dis Primers; 2019 Sep; 5(1):62. PubMed ID: 31515515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
    Leathem AM
    Clin Pharm; 1986 Aug; 5(8):660-8. PubMed ID: 2874910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy.
    Bsat FA; Hoffman DE; Seubert DE
    J Perinatol; 2003 Oct; 23(7):531-5. PubMed ID: 14566347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.
    Oliveira LG; Capp SM; You WB; Riffenburgh RH; Carstairs SD
    Obstet Gynecol; 2014 Oct; 124(4):735-742. PubMed ID: 25198265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pharmacologic treatment for nausea and vomiting of pregnancy.
    Fantasia HC
    Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
    Madjunkova S; Maltepe C; Koren G
    Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).
    Magee LA; Mazzotta P; Koren G
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S256-61. PubMed ID: 12011897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study.
    Fiaschi L; Nelson-Piercy C; Deb S; King R; Tata LJ
    BJOG; 2019 Sep; 126(10):1201-1211. PubMed ID: 30786126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE APPROACH TO NAUSEA AND VOMITING IN PREGNANCY].
    Shtomo M; Cohen R; Berkovitch M; Koren G
    Harefuah; 2015 Nov; 154(11):720-4, 741. PubMed ID: 26821506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nausea and vomiting of pregnancy: prevalence, severity and relation to psychosocial health.
    Kramer J; Bowen A; Stewart N; Muhajarine N
    MCN Am J Matern Child Nurs; 2013; 38(1):21-7. PubMed ID: 23232775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.